MIT chemists use generative AI to predict 3D genomic structures quickly, a process far faster than current methods.

Q4 2024 Earnings Call Transcript January 31, 2025 Revvity, Inc. misses on earnings expectations. Reported EPS is $0.778 EPS, ...

New research pinpoints 298 parts of the genome associated with higher risk of bipolar disorder. This could lead to better ...

The life sciences business is characterized by demands in preclinical discovery and research. Revvity has been able to offer a more complete workflow to customers in this segment, building off the ...

The firm reported that its full-year 2024 revenues were up slightly as a rise in the diagnostics business was mostly offset by a decline in life sciences business.

A significant advancement in knowledge of the link between cognition and genetics has been made thanks to a study led by ...

Q4 2024 Earnings Call Transcript January 30, 2025 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is ...

We are now entering the third decade of the 21st Century, and, especially in the last years, the achievements made by ...

EST Cathie Wood’s ARK Investment buys 370K shares of 10x Genomics (TXG) todayInvest with Confidence: Follow TipRanks' Top Wall Street ...

The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.